The tariff classification of Hetrazan (Diethylcarbamazinecitrate), a drug in bulk and dosage forms, and Caltrate Tablets,a high potency calcium supplement, from England and Australia
Reasoning
The tariff classification of Hetrazan (Diethylcarbamazinecitrate), a drug in bulk and dosage forms, and Caltrate Tablets,a high potency calcium supplement, from England and Australia
Cite this ruling
CBP Ruling 864162 (2933593000): The tariff classification of Hetrazan (Diethylcarbamazinecitrate), a drug in bulk and dosage forms, and Caltrate Tablets,a high potency calcium supplement, from England and Australia
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293359
The tariff classification of 6-Chloro-7-deazapurine (CAS 3680-69-1), imported in bulk form, from China
The tariff classification of 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (CAS 7365-45-9), imported in bulk form, from China
The tariff classification of Aprepitant (CAS-170729-80-3), Darifenacin (CAS-133099-04-4), and Eszopiclone (CAS-138729-47-2), imported in bulk form, from Italy and Spain
The tariff classification of Cis-2,6-dimethylpiperazine (CAS 108-49-6), imported in bulk form, from China
The tariff classification of Fluorouracil (CAS-51-21-8), imported in bulk form, from China